India to Georgia: Daratumumab Export Trade Route

The India to Georgia Daratumumab corridor is one of India's established pharmaceutical export routes, with 10 shipments documented worth a combined $59.1K USD. The route is dominated by G P INTERGLOBE, which alone accounts for roughly 91% of all export value, reflecting the consolidated nature of India's daratumumab manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $5.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with daratumumab's non-urgent bulk-order profile.

Shipment activity peaks during July–September, with an average transit time of 29 days port-to-port. The route has recorded an annual growth rate of 28.3%, placing it at rank #14 among India's top daratumumab export destinations globally.

On the import side, key buyers of Indian daratumumab in Georgia include MERMISI LLC, TO THE ORDER. MERMISI LLC is the single largest importer with 8 shipments valued at $54.0K USD.

India's daratumumab exports to Georgia are driven primarily by a handful of large-scale manufacturers. G P INTERGLOBE with 8 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Georgia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — G P INTERGLOBE, GNH INDIA PHARMACEUTICALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $5.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.

Beyond the primary product category, shipments on this route include closely related formulations such as daratumumab concentrate for solution forinfusion 400 mg, batch no.ngs6c01 mfg.dt.07/2023,exp.dt.06/2025 and daratumumab concentrate for solution for infusion 100 mgbatch no. ngs2501 mfg.dt. 07/2023, exp.dt. 06/2025, suggesting that buyers in Georgia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, MERMISI LLC is the largest importer with 8 shipments worth $54.0K USD — representing 91% of all daratumumab imports from India on this route.